Factor IX Inhibitors and Anaphylaxis in Hemophilia B-Reference-Cited by-同舟云学术

Factor IX Inhibitors and Anaphylaxis in Hemophilia B

Published:1997-01 Issue:1 Volume:19 Page:23-27
ISSN:0192-8562
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:Journal of Pediatric Hematology/Oncology

Author:

Warrier Indira,Ewenstein Bruce M.,Koerper Marion A.,Shapiro Amy,Key Nigel,DiMichele Donna,Miller Robert T.,Pasi John,Rivard Georges E.,Sommer Steve S.,Katz Jacob,Bergmann Frauke,Ljung Rolf,Petrini Pia,Lusher Jeanne M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference14 articles.

1. Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors

2. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

3. Urokinase-plasminogen activator in breast cancer

4. Gene Mutations and Inhibitor Formation in Patients with Hemophilia B

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology;Journal of Thrombosis and Haemostasis;2024-09

2. Successful immunosuppressive drug‐free immune tolerance induction in hemophilia B with inhibitor and anaphylaxis to factor IX: A case report;Clinical Case Reports;2024-08

3. A child diagnosed with severe hemophilia A presenting with nephrotic syndrome: a case report;Journal of Medical Case Reports;2023-05-20

4. Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China;Haemophilia;2022-09-26

5. Eradication of FIX inhibitor in haemophilia B children using low‐dose immune tolerance induction with rituximab‐based immunosuppressive agent(s) in China;Haemophilia;2022-05-03